Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease

Osamu Komiyama, Mitsuru Osano, Tadao Oikawa, Yoshiyuki Morikawa, Yoshifumi Kojima, Takayasu Murai, Jun Ishihara, Mitsuaki Tokumura, Nobuhiko Taguchi

Research output: Contribution to journalArticle

Abstract

Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.

Original languageEnglish
Pages (from-to)553-556
Number of pages4
JournalPediatrics International
Volume30
Issue number5
DOIs
Publication statusPublished - 1988

Fingerprint

Dinoprostone
Heart Diseases
Pulmonary Atresia
Ductus Arteriosus
Pharmaceutical Preparations
Therapeutics

Keywords

  • Blalock‐Taussig shunt
  • Ductus‐dependent congenital heart disease
  • Prostaglandin E1 and E2
  • Pulmonary atresia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Komiyama, O., Osano, M., Oikawa, T., Morikawa, Y., Kojima, Y., Murai, T., ... Taguchi, N. (1988). Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease. Pediatrics International, 30(5), 553-556. https://doi.org/10.1111/j.1442-200X.1988.tb01579.x

Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease. / Komiyama, Osamu; Osano, Mitsuru; Oikawa, Tadao; Morikawa, Yoshiyuki; Kojima, Yoshifumi; Murai, Takayasu; Ishihara, Jun; Tokumura, Mitsuaki; Taguchi, Nobuhiko.

In: Pediatrics International, Vol. 30, No. 5, 1988, p. 553-556.

Research output: Contribution to journalArticle

Komiyama, O, Osano, M, Oikawa, T, Morikawa, Y, Kojima, Y, Murai, T, Ishihara, J, Tokumura, M & Taguchi, N 1988, 'Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease', Pediatrics International, vol. 30, no. 5, pp. 553-556. https://doi.org/10.1111/j.1442-200X.1988.tb01579.x
Komiyama, Osamu ; Osano, Mitsuru ; Oikawa, Tadao ; Morikawa, Yoshiyuki ; Kojima, Yoshifumi ; Murai, Takayasu ; Ishihara, Jun ; Tokumura, Mitsuaki ; Taguchi, Nobuhiko. / Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease. In: Pediatrics International. 1988 ; Vol. 30, No. 5. pp. 553-556.
@article{77562c7092be4b7186e6bc62d9f351f0,
title = "Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease",
abstract = "Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.",
keywords = "Blalock‐Taussig shunt, Ductus‐dependent congenital heart disease, Prostaglandin E1 and E2, Pulmonary atresia",
author = "Osamu Komiyama and Mitsuru Osano and Tadao Oikawa and Yoshiyuki Morikawa and Yoshifumi Kojima and Takayasu Murai and Jun Ishihara and Mitsuaki Tokumura and Nobuhiko Taguchi",
year = "1988",
doi = "10.1111/j.1442-200X.1988.tb01579.x",
language = "English",
volume = "30",
pages = "553--556",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease

AU - Komiyama, Osamu

AU - Osano, Mitsuru

AU - Oikawa, Tadao

AU - Morikawa, Yoshiyuki

AU - Kojima, Yoshifumi

AU - Murai, Takayasu

AU - Ishihara, Jun

AU - Tokumura, Mitsuaki

AU - Taguchi, Nobuhiko

PY - 1988

Y1 - 1988

N2 - Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.

AB - Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.

KW - Blalock‐Taussig shunt

KW - Ductus‐dependent congenital heart disease

KW - Prostaglandin E1 and E2

KW - Pulmonary atresia

UR - http://www.scopus.com/inward/record.url?scp=84995047888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995047888&partnerID=8YFLogxK

U2 - 10.1111/j.1442-200X.1988.tb01579.x

DO - 10.1111/j.1442-200X.1988.tb01579.x

M3 - Article

C2 - 3144905

AN - SCOPUS:84995047888

VL - 30

SP - 553

EP - 556

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 5

ER -